Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Regulatory responses and approval status of artificial intelligence medical devices with a focus on China
29
Zitationen
3
Autoren
2024
Jahr
Abstract
This paper focuses on how regulatory bodies respond to artificial intelligence (AI)-enabled medical devices. To achieve this, we present a comparative overview of the United States (USA), European Union (EU), and China. Our search in the governmental database identified 59 AI medical devices approved in China as of July 2023. In comparison to the rules-based regulatory approach in China, the approaches in the USA and EU are more standards-oriented.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.551 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.443 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.942 Zit.
BioBERT: a pre-trained biomedical language representation model for biomedical text mining
2019 · 6.792 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.781 Zit.